We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Modified Smartphone-based System Automatically Determines Antibiotic Resistance

By LabMedica International staff writers
Posted on 27 Dec 2016
Print article
Image: A cutaway showing a smartphone and the diagnostic attachment for antimicrobial susceptibility testing (Photo courtesy of Dr. Aydogan Ozcan, University of California, Los Angeles).
Image: A cutaway showing a smartphone and the diagnostic attachment for antimicrobial susceptibility testing (Photo courtesy of Dr. Aydogan Ozcan, University of California, Los Angeles).
Microbiology researchers have described a modified smartphone that functions as an automated diagnostic test reader for the determination of antimicrobial resistance.

Routine antimicrobial susceptibility testing (AST) can prevent deaths due to bacteria and reduce the spread of multi-drug-resistance, but cannot be regularly performed in resource-limited-settings due to technological challenges, high-costs, and lack of trained professionals.

A team of investigators at the University of California, Los Angeles (USA) has reported the development of a cellphone-based 96-well microtiter-plate (MTP) reader, capable of performing AST without the need for trained diagnosticians.

The proposed system includes a three dimensional-printed smartphone attachment that holds and illuminates the MTP using a light-emitting-diode array. An inexpensive optical fiber-array enables the capture of the transmitted light of each well through the smartphone camera. A custom-designed application sends the captured image to a server to automatically determine well turbidity, with results returned to the smartphone in about one minute.

The investigators tested this mobile-reader on clinical isolates of Klebsiella pneumoniae containing highly resistant antimicrobial profiles using MTPs prepared with 17 antibiotics targeting Gram-negative bacteria. Using 78 patient isolate test-plates, they demonstrated that the mobile-reader met the [U.S.] Food and Drug Administration-defined AST criteria, with a well-turbidity detection accuracy of 98.21%, minimum-inhibitory-concentration accuracy of 95.12%, and a drug-susceptibility interpretation accuracy of 99.23%, with no very major errors.

"This work is extremely important and timely, given that drug-resistant bacteria are increasingly becoming a global threat rendering many of our first-line antibiotics ineffective," said senior author Dr. Aydogan Ozcan, professor of electrical engineering and bioengineering at the University of California, Los Angeles. "Our new smartphone-based technology can help put laboratory-quality testing into much wider adoption, especially in resource-limited regions."

The smartphone AST system was described in the December 15, 2016, online edition of the journal Scientific Reports.

Related Links:
University of California, Los Angeles

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: Comparison of traditional histopathology imaging vs. PARS raw data (Photo courtesy of University of Waterloo)

AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis

The process of biopsy is important for confirming the presence of cancer. In the conventional histopathology technique, tissue is excised, sliced, stained, mounted on slides, and examined under a microscope... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.